Benzodiazepine Drugs Market
Benzodiazepine Drugs Market Analysis, By Product (Alprazolam, Clonazepam, Diazepam, Lorazepam), By Time of Action (Ultra-short Acting, Short Acting, Long Acting), By Application (Anxiety, Insomnia, Alcohol Withdrawal), By Distribution Channel - Market Insights 2022 to 2032
Analysis of Benzodiazepine Drugs market covering 30 + countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Benzodiazepine Drugs Market Outlook (2022 to 2032)
The global benzodiazepine drugs market is worth US$ 2.35 billion in 2022 and is forecasted to progress at a CAGR of 2.8% to reach a market size of US$ 3.1 billion by the end of 2032.
Sales of benzodiazepine drugs are directly reliant on mental disorders, and North America is set to be the most favorable regional market for benzodiazepine drug manufacturers over the coming years.
| Report Attributes | Details |
|---|---|
| Benzodiazepine Drugs Market Size (2021A) | US$ 2.28 Billion |
| Estimated Market Value (2022E) | US$ 2.35 Billion |
| Forecasted Market Value (2032F) | US$ 3.1 Billion |
| Global Market Growth Rate (2022 to 2032) | 2.8% CAGR |
| North America Market Share (2021) | ~ 37.2% |
| Europe Market Growth Rate (2022 to 2032) | ~ 2.5% CAGR |
| United States Market Growth Rate (2022 to 2032) | ~ 2.1% CAGR |
| Market Share of Top 5 Companies | ~ 24.6% |
| Key Companies Profiled | Pfizer Inc.; Akorn Inc; Hikma; Hameln Pharmaceutical; Accord; troylab; Amneal Pharmaceuticals LLC; Apotex Inc. |
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Sales Analysis of Benzodiazepine Drugs (2017 to 2021) Vs. Market Estimations (2022 to 2032)
Benzodiazepine drugs have grabbed significant attention over the past few years due to intensified use of anxiolytics (flurazepam, triazolam, temazepam, etc.) and hypnotics (diazepam, alprazolam, lorazepam, etc.). Rising cases of mental disorders are leading to increasing prescriptions of benzodiazepine drugs across the world.
Furthermore, people's concern about alcohol consumption has elevated the use of benzodiazepine drugs to combat alcohol withdrawal symptoms. Also, investments in healthcare R&D have led to the introduction of novel synthesized benzodiazepines in the market.
These factors have amplified the sales of benzodiazepine drugs at a compound annual growth rate of 2.7% between 2017 and 2021.
Additionally, considerable growth in the cases of anxiety-related disorders among the global population will lead to high revenue generation for market players. Speedy urbanization and the present work culture have suggestively increased mental health problems, which will create a huge growth opportunity for the manufacturers of benzodiazepine drugs.
Fact.MR predicts that the global benzodiazepine drugs market will be valued at US$ 3.1 billion by 2032, expanding at a CAGR of 2.8%.
- Short Term (2022 to 2025): Rising use of benzodiazepine drugs for mental disorders will favorably affect market growth.
- Medium Term (2025 to 2028): Product development with minimal side effects will lead to huge acceptance of benzodiazepine drugs during the 2025 to 2028 period.
- Long Term (2028 to 2032): Rising urbanization and extraordinary work pressure will drive market growth over the long term.
Over the 2017 to 2021 historical period, the global market for benzodiazepine drugs registered a CAGR of 2.7%, and according to Fact.MR, a market research and competitive intelligence provider, it is projected to progress at 2.8% CAGR between 2022 and 2032.
Market share analysis of benzodiazepine drugs based on product and region. Under the product segment, alprazolam dominates with 29.6% market share.
Why Has the Consumption of Benzodiazepine Drugs Increased?
“Rising Prevalence of Anxiety & Insomnia across the World”
The escalating prevalence of anxiety disorders as well as amplified levels of stress in the global population have led to steady growth of the global benzodiazepines drugs market. Hectic and fast-moving lifestyles along with morbid work-life balance are influential factors that have increased mental health issues.
In addition, an increasing proportion of the millennial population is susceptible to anxiety disorders and depression.
- According to the study, the number of people suffering from anxiety-related disorders was 264 million across the world.
Moreover, unhealthful social judgments about mental health disorders owing to prolonged use of social networking platforms among millennials and teenagers is a key contributing factor supplementing market growth.
“Introduction of Novel Formulations under BZD Class and Increasing Product Approvals”
Investments in various clinical studies by government authorities and key market players are supporting the introduction of BZD drugs in the market. Market peers are concentrating on developing novel medicines for the treatment of anxiety and seizures, which is anticipated to spur the sales growth of benzodiazepine drugs throughout the forecast period.
Additionally, the upsurge of product approvals by regulatory bodies is benefiting market growth.
- For instance, Loreev XR received BZD product approval from the U.S. FDA in August 2021. It is used in the treatment of anxiety disorders, status epilepticus, anterograde amnesia in adults, and preoperative sedation.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
How is Benzodiazepine Drugs Market Growth Being Negatively Impacted?
“Growing Awareness Regarding CBT (Cognitive Behavioral Therapy)”
Various clinical studies have seen billions or trillion dollars spent on the development and establishment of psychotherapies across the world. This is now becoming a part of a million people’s lifestyles.
To reduce the overdependence on BZD, millions of people who are suffering from mental disorders are moving toward CBT treatment. The growing use of social media supports spreading awareness regarding the importance of mental health and related therapies such as CBT and effective anti-depressants.
Additionally, government agencies are also trying to create awareness regarding cognitive behavioral therapy to reduce dependence on BZD drugs and related side effects. Also, supportive resources provided by government authorities to their citizens are increasing the affordability of these services. Such initiatives in favor of CBT treatment may hinder the sales of benzodiazepine drugs to some extent.
Country-wise Insights
Will Increasing Anxiety Cases in the U.S. Lead to High Demand for Benzodiazepine Drugs?
In North America, the U.S. is ruling the market due to an upsurge in the incidence of anxiety and related circumstances as well as more FDA approvals of benzodiazepine drugs.
- According to the Anxiety and Depression Association of America (ADAA), in the United States, around 40 million adults are affected every year with anxiety disorders, out of which, only 36.9% prefer to take treatment.
Additionally, a surge in the expansion of mental healthcare services and growing consciousness about anxiety disorders are accountable for the growth in the diagnosis of GAD (generalized anxiety disorder).
The U.S. benzodiazepine drugs market is predicted to expand at a CAGR of 2.1% during the forecast period.
Why is the APAC Benzodiazepine Drugs Market Expected to Be Highly Opportunistic?
The APAC market accounted for 21.7% share of the global benzodiazepine drugs market at the end of 2021.
The growing population and stressful lifestyle in East Asia and South Asia and the ASEAN region are making this an opportunistic market for industry players.
Furthermore, developing healthcare facilities as well as an increase in government initiatives will support market growth in Japan. Also, a large number of generic manufacturers and specialist communities will drive market growth in the Asia Pacific region.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Category-wise Insights
What Has Made Alprazolam the Most Popular Product in This Market?
The benzodiazepine drugs market, under product segment, is categorized into alprazolam, clonazepam, diazepam, lorazepam, and others. Amongst them, the alprazolam segment held the largest market share of 29.2% in 2021 and is expected to exhibit a CAGR of 3% during the forecast years of 2022 to 2032.
Alprazolam enjoys high popularity owing to its identity as a high-potency triazolobenzodiazepine, which is approved by the US FDA for the treatment of anxiety and panic disorders.
Hence, extensive utilization of alprazolam for the treatment of anxiety and panic disorders and a higher number of prescriptions of alprazolam for these conditions are likely to drive segment growth through 2032.
Which Time of Action is Most Preferred?
Under time of action, benzodiazepine drugs are segmented into ultra-short acting, short-acting, and long-acting. Short-acting benzodiazepines are the most popular holding a majority share in the global market. It is anticipated to follow the same trend during the forecast period. The short-acting segment is projected to hold 77.1% share of the market by 2032.
However, ultra-short acting is the most promising segment for market players as well as emerging companies. Rapid expansion of the segment is due to the rise in popularity due to its pharmacokinetic activity and less chances of the development of drug dependency.
Competitive Landscape
Prominent benzodiazepine drugs manufacturers are Pfizer, Alkorn Inc., Hikma, Hameln Pharmaceutical, Accord, Troylab, Amneal Pharmaceuticals LLC, and Apotex Inc.
Benzodiazepine drug suppliers are investing their time and money in R&D activities to enhance the effectiveness of benzodiazepine drugs used for insomnia, anxiety reduction, and seizure treatment with minimum side effects.
Key market players are also adopting inorganic strategies such as acquisitions, mergers, partnerships, and joint ventures to uphold their presence in the market. Moreover, emerging as well as mid-level manufacturers are competing with each other for faster product approvals to launch their products in the market.
- In August 2022, Aquestive Therapeutics, Inc, a pharmaceutical company, received FDA approval for Libervant™, which is a diazepam-based buccal film for acute treatment of seizures.
- In June 2022, Hikma Pharmaceuticals Plc announced the establishment of Hikma France S.A.S.
- In February 2021, Akorn, a leading specialty pharmaceutical company, announced the review of strategic alternatives for its Consumer Health Business.
Fact.MR has provided detailed information about the price points of key manufacturers of Benzodiazepine Drugs positioned across regions, sales growth, production capacity, and speculative technological expansion, in the recently published report.
Segmentation of Benzodiazepine Drugs Industry Research
-
By Product :
- Alprazolam
- Clonazepam
- Diazepam
- Lorazepam
- Others
-
By Time of Action :
- Ultra-short Acting
- Short Acting
- Long Acting
-
By Application :
- Anxiety
- Insomnia
- Alcohol Withdrawal
- Seizures
- Others
-
By Distribution Channel :
- Hospital Pharmacies
- Retail Pharmacies
- Others
-
By Region :
- North America
- Latin America
- Europe
- East Asia
- South Asia & ASEAN
- Oceania
- MEA
Table of Content
- 1. Market - Executive Summary
- 2. Market Overview
- 3. Market Background and Foundation Data
- 4. Global Market Value (US$ Million) Analysis and Forecast
- 5. Global Market Analysis and Forecast, By Product Type
- 5.1. Alprazolam
- 5.2. Clonazepam
- 5.3. Diazepam
- 5.4. Lorazepam
- 5.5. Others
- 6. Global Market Analysis and Forecast, By Time of Action
- 6.1. Ultra-short Acting
- 6.2. Short Acting
- 6.3. Long Acting
- 7. Global Market Analysis and Forecast, By Application
- 7.1. Anxiety
- 7.2. Seizures
- 7.3. Insomnia
- 7.4. Alcohol Withdrawal
- 7.5. Others
- 8. Global Market Analysis and Forecast, By Distribution Channel
- 8.1. Hospital Pharmacies
- 8.2. Retail Pharmacies
- 8.3. Others
- 9. Global Market Analysis and Forecast, By Region
- 9.1. North America
- 9.2. Latin America
- 9.3. Europe
- 9.4. East Asia
- 9.5. South Asia & ASEAN
- 9.6. Oceania
- 9.7. Middle East & Africa
- 10. North America Market Analysis and Forecast
- 11. Latin America Market Analysis and Forecast
- 12. Europe Market Analysis and Forecast
- 13. East Asia Market Analysis and Forecast
- 14. South Asia & ASEAN Market Analysis and Forecast
- 15. Oceania Market Analysis and Forecast
- 16. Middle East & Africa Market Analysis and Forecast
- 17. Country-level Market Analysis and Forecast
- 18. Market Structure Analysis
- 19. Market Competition Analysis
- 19.1. Pfizer Inc.
- 19.2. Akorn Inc
- 19.3. Hikma
- 19.4. Hameln Pharmaceutical
- 19.5. Accord
- 19.6. Troylab
- 19.7. Amneal Pharmaceuticals LLC
- 19.8. Apotex Inc.
- 20. Assumptions & Acronyms Used
- 21. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Market Value (USD Million) and Forecast by Region, 2017 to 2021
Table 02: Global Market Value (USD Million) and Forecast by Region, 2022 to 2032
Table 03: Global Market Value (USD Million) and Forecast by Product Type, 2017 to 2021
Table 04: Global Market Value (USD Million) and Forecast by Product Type, 2022 to 2032
Table 05: Global Market Value (USD Million) and Forecast by Time of Action, 2017 to 2021
Table 06: Global Market Value (USD Million) and Forecast by Time of Action, 2022 to 2032
Table 07: Global Market Value (USD Million) and Forecast by Application, 2017 to 2021
Table 08: Global Market Value (USD Million) and Forecast by Application, 2022 to 2032
Table 09: Global Market Value (USD Million) and Forecast by Distribution Channel, 2017 to 2021
Table 10: Global Market Value (USD Million) and Forecast by Distribution Channel, 2022 to 2032
Table 11: North America Market Value (USD Million) and Forecast by Country, 2017 to 2021
Table 12: North America Market Value (USD Million) and Forecast by Country, 2022 to 2032
Table 13: North America Market Value (USD Million) and Forecast by Product Type, 2017 to 2021
Table 14: North America Market Value (USD Million) and Forecast by Product Type, 2022 to 2032
Table 15: North America Market Value (USD Million) and Forecast by Time of Action, 2017 to 2021
Table 16: North America Market Value (USD Million) and Forecast by Time of Action, 2022 to 2032
Table 17: North America Market Value (USD Million) and Forecast by Application, 2017 to 2021
Table 18: North America Market Value (USD Million) and Forecast by Application, 2022 to 2032
Table 19: North America Market Value (USD Million) and Forecast by Distribution Channel, 2017 to 2021
Table 20: North America Market Value (USD Million) and Forecast by Distribution Channel, 2022 to 2032
Table 21: Europe Market Value (USD Million) and Forecast by Country, 2017 to 2021
Table 22: Europe Market Value (USD Million) and Forecast by Country, 2022 to 2032
Table 23: Europe Market Value (USD Million) and Forecast by Product Type, 2017 to 2021
Table 24: Europe Market Value (USD Million) and Forecast by Product Type, 2022 to 2032
Table 25: Europe Market Value (USD Million) and Forecast by Time of Action, 2017 to 2021
Table 26: Europe Market Value (USD Million) and Forecast by Time of Action, 2022 to 2032
Table 27: Europe Market Value (USD Million) and Forecast by Application, 2017 to 2021
Table 28: Europe Market Value (USD Million) and Forecast by Application, 2022 to 2032
Table 29: Europe Market Value (USD Million) and Forecast by Distribution Channel, 2017 to 2021
Table 30: Europe Market Value (USD Million) and Forecast by Distribution Channel, 2022 to 2032
Table 31: East Asia Market Value (USD Million) and Forecast by Country, 2017 to 2021
Table 32: East Asia Market Value (USD Million) and Forecast by Country, 2022 to 2032
Table 33: East Asia Market Value (USD Million) and Forecast by Product Type, 2017 to 2021
Table 34: East Asia Market Value (USD Million) and Forecast by Product Type, 2022 to 2032
Table 35: East Asia Market Value (USD Million) and Forecast by Time of Action, 2017 to 2021
Table 36: East Asia Market Value (USD Million) and Forecast by Time of Action, 2022 to 2032
Table 37: East Asia Market Value (USD Million) and Forecast by Application, 2017 to 2021
Table 38: East Asia Market Value (USD Million) and Forecast by Application, 2022 to 2032
Table 39: East Asia Market Value (USD Million) and Forecast by Distribution Channel, 2017 to 2021
Table 40: East Asia Market Value (USD Million) and Forecast by Distribution Channel, 2022 to 2032
Table 41: South Asia & Oceania Market Value (USD Million) and Forecast by Country, 2017 to 2021
Table 42: South Asia & Oceania Market Value (USD Million) and Forecast by Country, 2022 to 2032
Table 43: South Asia & Oceania Market Value (USD Million) and Forecast by Product Type, 2017 to 2021
Table 44: South Asia & Oceania Market Value (USD Million) and Forecast by Product Type, 2022 to 2032
Table 45: South Asia & Oceania Market Value (USD Million) and Forecast by Time of Action, 2017 to 2021
Table 46: South Asia & Oceania Market Value (USD Million) and Forecast by Time of Action, 2022 to 2032
Table 47: South Asia & Oceania Market Value (USD Million) and Forecast by Application, 2017 to 2021
Table 48: South Asia & Oceania Market Value (USD Million) and Forecast by Application, 2022 to 2032
Table 49: South Asia & Oceania Market Value (USD Million) and Forecast by Distribution Channel, 2017 to 2021
Table 50: South Asia & Oceania Market Value (USD Million) and Forecast by Distribution Channel, 2022 to 2032
Table 51: MEA Market Value (USD Million) and Forecast by Country, 2017 to 2021
Table 52: MEA Market Value (USD Million) and Forecast by Country, 2022 to 2032
Table 53: MEA Market Value (USD Million) and Forecast by Product Type, 2017 to 2021
Table 54: MEA Market Value (USD Million) and Forecast by Product Type, 2022 to 2032
Table 55: MEA Market Value (USD Million) and Forecast by Time of Action, 2017 to 2021
Table 56: MEA Market Value (USD Million) and Forecast by Time of Action, 2022 to 2032
Table 57: MEA Market Value (USD Million) and Forecast by Application, 2017 to 2021
Table 58: MEA Market Value (USD Million) and Forecast by Application, 2022 to 2032
Table 59: MEA Market Value (USD Million) and Forecast by Distribution Channel, 2017 to 2021
Table 60: MEA Market Value (USD Million) and Forecast by Distribution Channel, 2022 to 2032
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Market Value (USD Million) Forecast, 2022 to 2032
Figure 02: Global Market Absolute $ Opportunity (USD Million), 2022 to 2032
Figure 03: Global Market Value (USD Million) by Region, 2022 & 2032
Figure 04: Global Market Y-o-Y Growth Rate by Region, 2022 to 2032
Figure 05: Global Market Value (USD Million) by Product Type, 2022 & 2032
Figure 06: Global Market Y-o-Y Growth Rate by Product Type, 2022 to 2032
Figure 07: Global Market Value (USD Million) by Time of Action, 2022 & 2032
Figure 08: Global Market Y-o-Y Growth Rate by Time of Action, 2022 to 2032
Figure 09: Global Market Value (USD Million) by Application, 2022 & 2032
Figure 10: Global Market Y-o-Y Growth Rate by Application, 2022 to 2032
Figure 11: Global Market Value (USD Million) by Distribution Channel, 2022 & 2032
Figure 12: Global Market Y-o-Y Growth Rate by Distribution Channel, 2022 to 2032
Figure 13: North America Market Value (USD Million) Forecast, 2022 to 2032
Figure 14: North America Market Absolute $ Opportunity (USD Million), 2022 to 2032
Figure 15: North America Market Value (USD Million) by Country, 2022 & 2032
Figure 16: North America Market Y-o-Y Growth Rate by Country, 2022 to 2032
Figure 17: North America Market Value (USD Million) by Product Type, 2022 & 2032
Figure 18: North America Market Y-o-Y Growth Rate by Product Type, 2022 to 2032
Figure 19: North America Market Value (USD Million) by Time of Action, 2022 & 2032
Figure 20: North America Market Y-o-Y Growth Rate by Time of Action, 2022 to 2032
Figure 21: North America Market Value (USD Million) by Application, 2022 & 2032
Figure 22: North America Market Y-o-Y Growth Rate by Application, 2022 to 2032
Figure 23: North America Market Value (USD Million) by Distribution Channel, 2022 & 2032
Figure 24: North America Market Y-o-Y Growth Rate by Distribution Channel, 2022 to 2032
Figure 25: North America Market Attractiveness Analysis by Country, 2022 to 2032
Figure 26: North America Market Attractiveness Analysis by Product Type, 2022 to 2032
Figure 27: North America Market Attractiveness Analysis by Time of Action, 2022 to 2032
Figure 28: North America Market Attractiveness Analysis by Application, 2022 to 2032
Figure 29: North America Market Attractiveness Analysis by Distribution Channel, 2022 to 2032
Figure 30: Latin America Market Value (USD Million) Forecast, 2022 to 2032
Figure 31: Latin America Market Absolute $ Opportunity (USD Million), 2022 to 2032
Figure 32: Latin America Market Value (USD Million) by Country, 2022 & 2032
Figure 33: Latin America Market Y-o-Y Growth Rate by Country, 2022 to 2032
Figure 34: Latin America Market Value (USD Million) by Product Type, 2022 & 2032
Figure 35: Latin America Market Y-o-Y Growth Rate by Product Type, 2022 to 2032
Figure 36: Latin America Market Value (USD Million) by Time of Action, 2022 & 2032
Figure 37: Latin America Market Y-o-Y Growth Rate by Time of Action, 2022 to 2032
Figure 38: Latin America Market Value (USD Million) by Application, 2022 & 2032
Figure 39: Latin America Market Y-o-Y Growth Rate by Application, 2022 to 2032
Figure 40: Latin America Market Value (USD Million) by Distribution Channel, 2022 & 2032
Figure 41: Latin America Market Y-o-Y Growth Rate by Distribution Channel, 2022 to 2032
Figure 42: Latin America Market Attractiveness Analysis by Country, 2022 to 2032
Figure 43: Latin America Market Attractiveness Analysis by Product Type, 2022 to 2032
Figure 44: Latin America Market Attractiveness Analysis by Time of Action, 2022 to 2032
Figure 45: Latin America Market Attractiveness Analysis by Application, 2022 to 2032
Figure 46: Latin America Market Attractiveness Analysis by Distribution Channel, 2022 to 2032
Figure 47: Europe Market Value (USD Million) Forecast, 2022 to 2032
Figure 48: Europe Market Absolute $ Opportunity (USD Million), 2022 to 2032
Figure 49: Europe Market Value (USD Million) by Country, 2022 & 2032
Figure 50: Europe Market Y-o-Y Growth Rate by Country, 2022 to 2032
Figure 51: Europe Market Value (USD Million) by Product Type, 2022 & 2032
Figure 52: Europe Market Y-o-Y Growth Rate by Product Type, 2022 to 2032
Figure 53: Europe Market Value (USD Million) by Time of Action, 2022 & 2032
Figure 54: Europe Market Y-o-Y Growth Rate by Time of Action, 2022 to 2032
Figure 55: Europe Market Value (USD Million) by Application, 2022 & 2032
Figure 56: Europe Market Y-o-Y Growth Rate by Application, 2022 to 2032
Figure 57: Europe Market Value (USD Million) by Distribution Channel, 2022 & 2032
Figure 58: Europe Market Y-o-Y Growth Rate by Distribution Channel, 2022 to 2032
Figure 59: Europe Market Attractiveness Analysis by Country, 2022 to 2032
Figure 60: Europe Market Attractiveness Analysis by Product Type, 2022 to 2032
Figure 61: Europe Market Attractiveness Analysis by Time of Action, 2022 to 2032
Figure 62: Europe Market Attractiveness Analysis by Application, 2022 to 2032
Figure 63: Europe Market Attractiveness Analysis by Distribution Channel, 2022 to 2032
Figure 64: East Asia Market Value (USD Million) Forecast, 2022 to 2032
Figure 65: East Asia Market Absolute $ Opportunity (USD Million), 2022 to 2032
Figure 66: East Asia Market Value (USD Million) by Country, 2022 & 2032
Figure 67: East Asia Market Y-o-Y Growth Rate by Country, 2022 to 2032
Figure 68: East Asia Market Value (USD Million) by Product Type, 2022 & 2032
Figure 69: East Asia Market Y-o-Y Growth Rate by Product Type, 2022 to 2032
Figure 70: East Asia Market Value (USD Million) by Time of Action, 2022 & 2032
Figure 71: East Asia Market Y-o-Y Growth Rate by Time of Action, 2022 to 2032
Figure 72: East Asia Market Value (USD Million) by Application, 2022 & 2032
Figure 73: East Asia Market Y-o-Y Growth Rate by Application, 2022 to 2032
Figure 74: East Asia Market Value (USD Million) by Distribution Channel, 2022 & 2032
Figure 75: East Asia Market Y-o-Y Growth Rate by Distribution Channel, 2022 to 2032
Figure 76: East Asia Market Attractiveness Analysis by Country, 2022 to 2032
Figure 77: East Asia Market Attractiveness Analysis by Product Type, 2022 to 2032
Figure 78: East Asia Market Attractiveness Analysis by Time of Action, 2022 to 2032
Figure 79: East Asia Market Attractiveness Analysis by Application, 2022 to 2032
Figure 80: East Asia Market Attractiveness Analysis by Distribution Channel, 2022 to 2032
Figure 81: South Asia Market Value (USD Million) Forecast, 2022 to 2032
Figure 82: South Asia Market Absolute $ Opportunity (USD Million), 2022 to 2032
Figure 83: South Asia Market Value (USD Million) by Country, 2022 & 2032
Figure 84: South Asia Market Y-o-Y Growth Rate by Country, 2022 to 2032
Figure 85: South Asia Market Value (USD Million) by Product Type, 2022 & 2032
Figure 86: South Asia Market Y-o-Y Growth Rate by Product Type, 2022 to 2032
Figure 87: South Asia Market Value (USD Million) by Time of Action, 2022 & 2032
Figure 88: South Asia Market Y-o-Y Growth Rate by Time of Action, 2022 to 2032
Figure 89: South Asia Market Value (USD Million) by Application, 2022 & 2032
Figure 90: South Asia Market Y-o-Y Growth Rate by Application, 2022 to 2032
Figure 91: South Asia Market Value (USD Million) by Distribution Channel, 2022 & 2032
Figure 92: South Asia Market Y-o-Y Growth Rate by Distribution Channel, 2022 to 2032
Figure 93: South Asia Market Attractiveness Analysis by Country, 2022 to 2032
Figure 94: South Asia Market Attractiveness Analysis by Product Type, 2022 to 2032
Figure 95: South Asia Market Attractiveness Analysis by Time of Action, 2022 to 2032
Figure 96: South Asia Market Attractiveness Analysis by Application, 2022 to 2032
Figure 97: South Asia Market Attractiveness Analysis by Distribution Channel, 2022 to 2032
Figure 98: Oceania Market Value (USD Million) Forecast, 2022 to 2032
Figure 99: Oceania Market Absolute $ Opportunity (USD Million), 2022 to 2032
Figure 100: Oceania Market Value (USD Million) by Country, 2022 & 2032
Figure 101: Oceania Market Y-o-Y Growth Rate by Country, 2022 to 2032
Figure 102: Oceania Market Value (USD Million) by Product Type, 2022 & 2032
Figure 103: Oceania Market Y-o-Y Growth Rate by Product Type, 2022 to 2032
Figure 104: Oceania Market Value (USD Million) by Time of Action, 2022 & 2032
Figure 105: Oceania Market Y-o-Y Growth Rate by Time of Action, 2022 to 2032
Figure 106: Oceania Market Value (USD Million) by Application, 2022 & 2032
Figure 107: Oceania Market Y-o-Y Growth Rate by Application, 2022 to 2032
Figure 108: Oceania Market Value (USD Million) by Distribution Channel, 2022 & 2032
Figure 109: Oceania Market Y-o-Y Growth Rate by Distribution Channel, 2022 to 2032
Figure 110: Oceania Market Attractiveness Analysis by Country, 2022 to 2032
Figure 111: Oceania Market Attractiveness Analysis by Product Type, 2022 to 2032
Figure 112: Oceania Market Attractiveness Analysis by Time of Action, 2022 to 2032
Figure 113: Oceania Market Attractiveness Analysis by Application, 2022 to 2032
Figure 114: Oceania Market Attractiveness Analysis by Distribution Channel, 2022 to 2032
Figure 115: MEA Market Value (USD Million) Forecast, 2022 to 2032
Figure 116: MEA Market Absolute $ Opportunity (USD Million), 2022 to 2032
Figure 117: MEA Market Value (USD Million) by Country, 2022 & 2032
Figure 118: MEA Market Y-o-Y Growth Rate by Country, 2022 to 2032
Figure 119: MEA Market Value (USD Million) by Product Type, 2022 & 2032
Figure 120: MEA Market Y-o-Y Growth Rate by Product Type, 2022 to 2032
Figure 121: MEA Market Value (USD Million) by Time of Action, 2022 & 2032
Figure 122: MEA Market Y-o-Y Growth Rate by Time of Action, 2022 to 2032
Figure 123: MEA Market Value (USD Million) by Application, 2022 & 2032
Figure 124: MEA Market Y-o-Y Growth Rate by Application, 2022 to 2032
Figure 125: MEA Market Value (USD Million) by Distribution Channel, 2022 & 2032
Figure 126: MEA Market Y-o-Y Growth Rate by Distribution Channel, 2022 to 2032
Figure 127: MEA Market Attractiveness Analysis by Country, 2022 to 2032
Figure 128: MEA Market Attractiveness Analysis by Product Type, 2022 to 2032
Figure 129: MEA Market Attractiveness Analysis by Time of Action, 2022 to 2032
Figure 130: MEA Market Attractiveness Analysis by Application, 2022 to 2032
Figure 131: MEA Market Attractiveness Analysis by Distribution Channel, 2022 to 2032
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
What valuation does the benzodiazepine drugs market enjoy?
The global benzodiazepine drugs market is valued at US$ 2.35 billion in 2022.
How is the market expected to progress over the decade?
Sales of benzodiazepine drugs are anticipated to reach US$ 3.1 billion by the end of 2032.
Which type of benzodiazepine drug is most widely prescribed?
Alprazolam accounts for 29.2% share of the global BZD drugs market.
How has the North America benzodiazepine drugs market fared?
North America leads the global market with 37.1% share.
What was the CAGR for the market between 2017 and 2021?
Revenue from the benzodiazepine drugs market increased at 2.7% CAGR from 2017 to 2021.
Benzodiazepine Drugs Market